Skip to main content

Oncolytics Bio(ONC-T)
TSX

Today's Change
Real-Time Last Update

Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN

Newswire.ca - Tue Mar 5, 6:00AM CST

US$5M grant supports study of pelareorep in combination with modified FOLFIRINOX +/- atezolizumab

Testing with the most common therapies could facilitate broad use of pelareorep in pancreatic cancer patients

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe